LSUHSC research identifies new therapeutic target for Alzheimer's disease
2012-11-01
(Press-News.org) New Orleans, LA – Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent Alzheimer's disease. The study was published online November 1, 2012 in the Online Now section of the journal Cell Reports.
The research team found that inactivation of MAGL, best known for its role in degrading a cannabinoid produced in the brain, reduced the production and accumulation of beta amyloid plaques, a pathological hallmark of Alzheimer's disease. Inhibition of this enzyme also decreased neuroinflammation and neurodegeneration, and improved plasticity of the brain, learning and memory.
"Our results suggest that MAGL contributes to the cause and development of Alzheimer's disease and that blocking MAGL represents a promising therapeutic target," notes Dr. Chu Chen, who is also a member of the Department of Otolaryngology at LSU Health Sciences Center New Orleans.
The researchers blocked MAGL with a highly selective and potent inhibitor in mice using different dosing regimens and found that inactivation of MAGL for eight weeks was sufficient to decrease production and deposition of beta amyloid plaques and the function of a gene involved in making beta amyloid toxic to brain cells. They also measured indicators of neuroinflammation and neurodegeneration and found them suppressed when MAGL was inhibited. The team discovered that not only did the integrity of the structure and function of synapses associated with cognition remain intact in treated mice, but MAGL inactivation appeared to promote spatial learning and memory, measured with behavioral testing.
Alzheimer's disease is a neurodegenerative disorder characterized by accumulation and
deposition of amyloid plaques and neurofibrillary tangles, neuroinflammation, synaptic
dysfunction, progressive deterioration of cognitive function and loss of memory in association
with widespread nerve cell death. The most common cause of dementia among older people, more than 5.4 million people in the United States and 36 million people worldwide suffer with Alzheimer's disease in its various stages. Unfortunately, the few drugs that are currently approved by the Food and Drug Administration have demonstrated only modest effects in modifying the clinical symptoms for relatively short periods, and none has shown a clear effect on disease progression or prevention.
"There is a great public health need to discover new therapies to prevent and treat this devastating disorder," Dr. Chen concludes.
The research was supported by grants from the National Institutes of Health. In addition to scientists from LSU Health Sciences Center New Orleans, the research team also included investigators from the Massachusetts Institute of Technology.
###
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC New Orleans consists of a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, Schools of Allied Health Professions and Graduate Studies, and the only School of Nursing within an academic health center in the State of Louisiana. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth.
ELSE PRESS RELEASES FROM THIS DATE:
Rethinking reading
2012-11-01
Many educators have long believed that when words differ on only one sound, early readers can learn the rules of phonics by focusing on what is different between the words. This is thought to be a critical gateway to reading words and sentences.
But scientists at the University of Iowa are turning that thinking on its head. A recent study published in "Developmental Psychology" shows certain kinds of variation in words may help early readers learn better. When children see the same phonics regularities, embedded in words with more variation, they may learn these crucial ...
Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
2012-11-01
Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.
The Johns Hopkins researchers say their crisscrossing optical images, made by shining a laser back and forth across a biopsied tissue sample a few millionths of a meter thick, can potentially be used with other tests to more accurately determine the need for lymph node biopsy ...
George Mason University researchers target breast cancer in 3 trials
2012-11-01
Fairfax, Va. -- A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.
"The bold long-term goal is a short-term oral treatment that prevents breast cancer by killing the precursor cells that initiate breast cancer," says Lance Liotta, co-director of Mason's Center for Applied Proteomics and Molecular Medicine (CAPMM). "And it's looking hopeful."
The PINC trial (Preventing Invasive Neoplasia with Chloroquine) targets ductal carcinoma in situ, or DCIS, the most common type of pre-invasive ...
Researchers use blood testing to predict level of enzymes that facilitate disease progression
2012-11-01
Predicting how atherosclerosis, osteoporosis or cancer will progress or respond to drugs in individual patients is difficult. In a new study, researchers took another step toward that goal by developing a technique able to predict from a blood sample the amount of cathepsins—protein-degrading enzymes known to accelerate these diseases—a specific person would produce.
This patient-specific information may be helpful in developing personalized approaches to treat these tissue-destructive diseases.
"We measured significant variability in the amount of cathepsins produced ...
Mice with 'humanized' livers improve early drug testing, Stanford scientists show
2012-11-01
STANFORD, Calif. — Stanford University School of Medicine scientists have used bioengineered mice with livers composed largely of human cells to characterize a drug about to enter early-stage clinical development for combating hepatitis C.
Tests using the new mouse model accurately predicted significant aspects of the drug's behavior in humans — including its interaction with another drug and the profile of its major breakdown products in the body (called metabolites) — far more accurately than would have been achieved using current methods.
The study will be published ...
Regional analysis masks substantial local variation in health care spending
2012-11-01
PITTSBURGH, Oct. 31, 2012 – Reforming Medicare payments based on large geographic regions may be too bluntly targeted to promote the best use of health care resources, a new analysis from the University of Pittsburgh Graduate School of Public Health suggests. The analysis will be published in the Nov. 1 issue of the New England Journal of Medicine.
"Much policy attention has been drawn to the large geographic variation in health care spending across regions, and for good reason – because regional variation points to inefficient use of resources," said lead author Yuting ...
Tabletop fault model reveals why some quakes result in faster shaking
2012-11-01
Berkeley — The more time it takes for an earthquake fault to heal, the faster the shake it will produce when it finally ruptures, according to a new study by engineers at the University of California, Berkeley, who conducted their work using a tabletop model of a quake fault.
"The high frequency waves of an earthquake — the kind that produces the rapid jolts — are not well understood because they are more difficult to measure and more difficult to model," said study lead author Gregory McLaskey, a former UC Berkeley Ph.D. student in civil and environmental engineering. ...
Unexpected factor contributes to melanoma risk in red-haired, fair-skinned individuals
2012-11-01
The well-established elevated risk of melanoma among people with red hair and fair skin may be caused by more than just a lack of natural protection against ultraviolet (UV) radiation. In an article receiving Advance Online Publication in Nature, Massachusetts General Hospital (MGH) Cutaneous Biology Research Center (CBRC)and Cancer Center researchers report finding that the type of skin pigment predominantly found in red-haired, fair-skinned individuals may itself contribute to the development of melanoma.
"We've known for a long time that people with red hair and ...
Pond skating insects reveal water-walking secrets
2012-11-01
This month's special issue of Physics World is devoted to animal physics, and includes science writer Stephen Ornes explanation of how pond skaters effortlessly skip across water leaving nothing but a small ripple in their wake.
As Ornes writes, our current understanding of the mechanisms adopted by the pond skater is down to the efforts of David Hu, who as a mathematics graduate from the Massachusetts Institute of Technology spent four years studying their behaviour.
Hu, along with his PhD supervisor John Bush, found that pond skaters use the middle of their three ...
Sleep duration affects hunger differently in men and women
2012-11-01
A new study suggests that increasing the amount of sleep that adults get could lead to reduced food intake, but the hormonal process differs between men and women.
"Restricting sleep in healthy, normal weight participants has limited effects on metabolic risk factors and may affect food intake regulating hormones differently in men and women," said Marie-Pierre St-Onge, PhD, FAHA, the study's principal investigator. "We were surprised by the lack of a significant effect of sleep on glucose and insulin, leptin, and sex differences in the hunger-stimulating hormone ghrelin ...